Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Ascentage Pharma's Olverembatinib Granted Orphan Designation by the European Commission for the Treatment of Chronic Myeloid Leukemia 2021-11-22 21:24
Alterity Therapeutics to Participate in Two Upcoming Investor Conferences 2021-11-22 20:50
Baidu Enters Into License Agreement With Sanofi to Enable Next-Generation mRNA Therapeutics and Vaccines 2021-11-22 20:00
CARsgen Receives CTA Authorization from Health Canada for CLDN18.2-targeted CAR T-cell Product CT041 2021-11-22 20:00
CStone Pharmaceuticals and Jiangsu Hengrui Pharmaceuticals announce strategic partnership and exclusive licensing agreement on anti-CTLA-4 monoclonal antibody CS1002 in Greater China 2021-11-21 17:02
Kangtai Adenovirus Vector COVID-19 Vaccine (KCONECAVAC) Exported for the First Time 2021-11-19 18:52
ASRA 2021 | Cali Biosciences Presents Phase IIa Clinical Data on CPL-01, a Long-Acting Ropivacaine 2021-11-19 13:14
Tavotek Biotherapeutics Announces Completion of Round B Financing with $35 Million 2021-11-19 08:00
OncoOne and GenScript ProBio Enter Agreement for the Manufacturing of Monoclonal Antibody Drugs Targeting oxMIF 2021-11-17 22:00
Terumo Blood and Cell Technologies and Immunicom Establish Agreement to Launch Breakthrough Cancer Immunotherapy Treatment in Europe 2021-11-17 00:00
FibroBiologics Secures $100 Million Capital Commitment from GEM as Company Seeks to Go Public 2021-11-16 23:07
Delivering Health with Science: Huison Virgin DHA at the World Congress of Omega-3 Science & Technology 2021-11-16 21:30
Happiness Development Group Limited Received Nasdaq Notification Letter Regarding Bid Price Deficiency 2021-11-16 21:00
Kazia Therapeutics Appoints John Friend, MD, as Chief Medical Officer 2021-11-16 00:00
CARsgen Announces CAR T-cell Product Candidate CT041 Granted PRIME Eligibility by the EMA 2021-11-15 22:10
Validation Study Showcases Success of LSBD's Rapid SARS-CoV-2 Antibody Test 2021-11-15 22:00
InnoCare Announces the Clearance of Clinical Trial of Novel SHP2 Allosteric Inhibitor ICP-189 by U.S. FDA 2021-11-15 08:30
China Pharma Holdings, Inc. Reports Third Quarter 2021 Financial Results 2021-11-13 05:30
Tabernacle Health Group Launches Revolutionary Immunity Booster. Natural Health Supplement Avrocil (TM) Treats Cold and Flu Symptoms caused by Upper Respiratory Tract Infections 2021-11-12 02:00
Lunit Presents Studies at SITC 2021, Highlighting the Effectiveness of AI in Predicting Response to Immunotherapy in a Clinical Trial Setting 2021-11-11 23:00